
Integrated Diagnostics Holdings Plc Notice of Results
18 November 2026
(London) Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan will publish its unaudited results for the nine months ended 30 September 2026 on Wednesday, 25 November 2026 at 7am (UK).
An analyst and investor call will be hosted at 1pm (UK) | 3pm (Egypt) on Monday, 7 December 2026. You can learn more details and register for the call by clicking on this link.
For more information about the event, please contact: amoataz@EFG-HERMES.com
–Ends–
About Integrated Diagnostics Holdings (IDH)
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests. From its base of 887 branches as of 30 September 2026, IDH serves nearly 10 million patients and performs over 40 million tests annually. IDH will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. Beyond organic growth, the Group targets expansion in appealing markets, including acquisitions in the Middle Eastern, African, and East Asian markets where its model is well-suited to capitalise on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity (i) whose shares are admitted to the equity shares (transition) category (previously, the standard listing segment) of the Official List of the UK Financial Conduct Authority and admitted to trading on the main market for listed securities of the London Stock Exchange (ticker: IDHC) since May 2015.
The person responsible for arranging the release of this announcement is Mirette Ahmed, Investor Relations and Investments Section Head at IDH.
Contact
Mirette Ahmed
Investor Relations and Investments Section Head
T: +20 (0)2 3332 1126 | M: +20 11 1784 7401 | mirette.ahmed@idhcorp.com